Walleye Trading’s Wave Life Sciences WVE Stock Holding History

Walleye Trading’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$144K	Sell	19,900 -2,300	-10%	-$30K	﹤0.01%	3291
2025 Q4	$377K	Buy	22,200 +21,700	+4,340%	+$220K	﹤0.01%	3004
2025 Q3	$3.66K	Buy	+500	New	+$4.04K	﹤0.01%	4258
2022 Q1	–	Sell	-200	Closed	-$1K	–	5974
2021 Q4	$1K	Buy	+200	New	+$830	﹤0.01%	5266
2021 Q1	–	Sell	-18,700	Closed	-$147K	–	5376
2020 Q4	$147K	Buy	+18,700	New	+$157K	﹤0.01%	3717
2020 Q2	–	Sell	-100	Closed	-$1K	–	4661
2020 Q1	$1K	Buy	+100	New	+$852	﹤0.01%	3873
2019 Q3	–	Sell	-3,000	Closed	-$78K	–	4493
2019 Q2	$78K	Buy	+3,000	New	+$84.1K	﹤0.01%	3399

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GSK plc London $599M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Walleye Trading's WVE Position: Q1 2026 in Review

Walleye Trading reduced its Wave Life Sciences (WVE) stake by 51% in Q1 2026, selling an estimated $221K and leaving 16,288 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #3387.

Walleye Trading first reported a position in WVE in Q4 2020 and has held it in 5 quarters since. The position peaked at $565K in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Walleye Trading held 16,288 shares of Wave Life Sciences worth $118K as of Q1 2026.
Walleye Trading sold 16,953 Wave Life Sciences shares in Q1 2026, an estimated $221K.
Wave Life Sciences made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3387 holding.
Walleye Trading first reported a position in Wave Life Sciences in Q4 2020 and has held it in 5 quarters since.
Walleye Trading's Wave Life Sciences position peaked at $565K in Q4 2025.
230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.